YU71603A - Kombinacija epotilonskih analoga i hemoterapeutskih agenasa u terapiji proliferativnih jedinjenja - Google Patents

Kombinacija epotilonskih analoga i hemoterapeutskih agenasa u terapiji proliferativnih jedinjenja

Info

Publication number
YU71603A
YU71603A YU71603A YUP71603A YU71603A YU 71603 A YU71603 A YU 71603A YU 71603 A YU71603 A YU 71603A YU P71603 A YUP71603 A YU P71603A YU 71603 A YU71603 A YU 71603A
Authority
YU
Yugoslavia
Prior art keywords
treatment
combination
chemotherapeutic agents
proliferative diseases
epothilone analogs
Prior art date
Application number
YU71603A
Other languages
English (en)
Inventor
Francis Y.F. Lee
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of YU71603A publication Critical patent/YU71603A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Prikazani su preparati i postupci korisni u lečenju i prevenciji proliferativnih bolesti.[The present invention provides use of a compound in the manufacture of a medicament to inhibit 11ГЎ-HSD activity, wherein the compound is selected from glycyrrhetinic acid derivatives, progesterone and progesterone derivatives.
YU71603A 2001-03-14 2002-03-05 Kombinacija epotilonskih analoga i hemoterapeutskih agenasa u terapiji proliferativnih jedinjenja YU71603A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60275801A 2001-03-14 2001-03-14
US31639501P 2001-08-31 2001-08-31

Publications (1)

Publication Number Publication Date
YU71603A true YU71603A (sh) 2006-05-25

Family

ID=47748799

Family Applications (1)

Application Number Title Priority Date Filing Date
YU71603A YU71603A (sh) 2001-03-14 2002-03-05 Kombinacija epotilonskih analoga i hemoterapeutskih agenasa u terapiji proliferativnih jedinjenja

Country Status (1)

Country Link
YU (1) YU71603A (sh)

Similar Documents

Publication Publication Date Title
GB0105772D0 (en) Use
PL365285A1 (en) Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
ZA200501098B (en) Novel use of benzothiazole derivatives
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
MXPA05001581A (es) Algunas imidazopiridinas novedosas y su uso.
NZ514234A (en) N-cyanomethylamides as protease inhibitors
MXPA04009163A (es) Nuevos compuestos.
MXPA04006553A (es) Compuesto de 4-oxoquinolina y uso del mismo como inhibidor de integrasa de vih.
HUP0400203A3 (en) Use of combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases, for preparation of pharmaceutical compositions
WO2001039762A3 (en) Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system
MXPA04012965A (es) Inhibidores virales.
SG148177A1 (en) Novel cis-imidazolines
WO2002096363A3 (en) Method for treating fibrotic diseases or other indications
EP0249735A3 (en) Pharmaceutical preparations comprising as active agent 2-phenyl-1.2-benzisoselenazol-3(2h)-one, for the treatment of diseases caused by oxidative stress
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
MY128014A (en) Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors
GB0130677D0 (en) Medicaments and novel compounds
MY133527A (en) Isoquinoline derivatives
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
NZ511559A (en) Use of staurosporine derivatives for treating ocular neovascular diseases
YU71603A (sh) Kombinacija epotilonskih analoga i hemoterapeutskih agenasa u terapiji proliferativnih jedinjenja
AU6826700A (en) Ceramide analogs, process for their preparation and their use as antitumor agents
EA200601514A1 (ru) Производные пиперазинмочевины для лечения эндометриоза
AU4258601A (en) Divided dose therapies with vascular damaging activity